Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.
Saag KG, Mohr PE, Esmail L, Mudano AS, Wright N, Beukelman T, Curtis JR, Cutter G, Delzell E, Gary LC, Harrington TM, Karkare S, Kilgore ML, Lewis CE, Moloney R, Oliveira A, Singh JA, Warriner A, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. Saag KG, et al. Among authors: beukelman t. Contemp Clin Trials. 2012 Nov;33(6):1211-6. doi: 10.1016/j.cct.2012.07.002. Epub 2012 Jul 5. Contemp Clin Trials. 2012. PMID: 22796098 Free PMC article.
Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
Hahn T, Daymont C, Beukelman T, Groh B, Hays K, Bingham CA, Scalzi L; and for the CARRA Registry investigators. Hahn T, et al. Among authors: beukelman t. Pediatr Rheumatol Online J. 2022 Dec 14;20(1):116. doi: 10.1186/s12969-022-00775-7. Pediatr Rheumatol Online J. 2022. PMID: 36517887 Free PMC article. No abstract available.
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Beukelman T, Tomlinson G, Nigrovic PA, Dennos A, Del Gaizo V, Jelinek M, Riordan ME, Schanberg LE, Mohan S, Pfeifer E, Kimura Y; CARRA FROST Investigators. Beukelman T, et al. Pediatr Rheumatol Online J. 2022 Dec 8;20(1):113. doi: 10.1186/s12969-022-00768-6. Pediatr Rheumatol Online J. 2022. PMID: 36482434 Free PMC article.
Attack phenotypes and disease course in pediatric MOGAD.
Santoro JD, Beukelman T, Hemingway C, Hokkanen SRK, Tennigkeit F, Chitnis T. Santoro JD, et al. Among authors: beukelman t. Ann Clin Transl Neurol. 2023 May;10(5):672-685. doi: 10.1002/acn3.51759. Epub 2023 Mar 31. Ann Clin Transl Neurol. 2023. PMID: 37000895 Free PMC article. Review.
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE; American College of Rheumatology. Saag KG, et al. Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721. Arthritis Rheum. 2008. PMID: 18512708 Free article. No abstract available.
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. Beukelman T, et al. Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460. Arthritis Care Res (Hoboken). 2011. PMID: 21452260 Free PMC article. Review.
170 results